In vitro activity of gatifloxacin alone and in combination with cefepime, meropenem, piperacillin and gentamicin against multidrug-resistant organisms.
about
In vitro activity effects of combinations of cephalothin, dicloxacillin, imipenem, vancomycin and amikacin against methicillin-resistant Staphylococcus spp. strainsSynergistic Effect of Oleanolic Acid on Aminoglycoside Antibiotics against Acinetobacter baumanniiEfficacy of Mastoparan-AF alone and in combination with clinically used antibiotics on nosocomial multidrug-resistant Acinetobacter baumanniiAntimicrobial activities of ceragenins against clinical isolates of resistant Staphylococcus aureus.Antimicrobial Effects and Resistant Regulation of Magnolol and Honokiol on Methicillin-Resistant Staphylococcus aureusCooperation of Doxycycline with Phytochemicals and Micronutrients Against Active and Persistent Forms of Borrelia spSynergistic effects and antibiofilm properties of chimeric peptides against multidrug-resistant Acinetobacter baumannii strains.Gatifloxacin ophthalmic solution for treatment of bacterial conjunctivitis: safety, efficacy and patient perspective.In vitro synergy of daptomycin plus rifampin against Enterococcus faecium resistant to both linezolid and vancomycin.S-Nitrosothiol-modified nitric oxide-releasing chitosan oligosaccharides as antibacterial agentsActivity of Chitosans in combination with antibiotics in Pseudomonas aeruginosa.Reciprocal cooperation of phytochemicals and micronutrients against typical and atypical forms of Borrelia sp.Antimicrobial susceptibility patterns of unusual nonfermentative gram-negative bacilli isolated from Latin America: report from the SENTRY Antimicrobial Surveillance Program (1997-2002).The impact of farnesol in combination with fluconazole on Candida albicans biofilm: regulation of ERG20, ERG9, and ERG11 genes.Synergistic Effects of n-Hexane Fraction of Parkia biglobosa (Jacq.) Bark Extract and Selected Antibiotics on Bacterial Isolates
P2860
Q21093290-30C418C5-1CDE-4CC4-9871-AC73AC22FC3EQ28547854-E64D004C-6725-417E-8ECC-90CAA8BFFB67Q33817950-8584C0C5-9F3B-4D61-B627-BEB75199401EQ35758983-B18D5C61-28A9-4D38-B706-AB60926DF2A7Q36017541-3A6E422E-80E0-4477-9DC6-AD1DB766F9CAQ37201989-95547725-C726-4682-B464-7F8D0C991727Q37643714-FB4927C7-46F9-4E20-99B0-EC21609830F1Q39675169-B341F94C-24FC-45A8-B755-ACF9D05955B3Q40667458-78F8711B-0CE6-43E6-AD89-8B9F348BACCFQ40952689-7F52F413-D771-454A-BF8F-AD122C9E2CD2Q41822159-942ECAB0-A4BA-4948-963A-CE23F2AC8BC1Q46345529-C7AA0987-595B-49FB-B1A1-8E81D825CE31Q46815367-A6CCD275-EF70-4E73-9C8A-AA7213B3A2ACQ47566416-E663FF7A-E165-4E47-AB83-D8F72A771ABEQ59239164-557131EF-F882-4438-926D-5D02DF7A4CB9
P2860
In vitro activity of gatifloxacin alone and in combination with cefepime, meropenem, piperacillin and gentamicin against multidrug-resistant organisms.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
In vitro activity of gatifloxa ...... multidrug-resistant organisms.
@en
In vitro activity of gatifloxa ...... multidrug-resistant organisms.
@nl
type
label
In vitro activity of gatifloxa ...... multidrug-resistant organisms.
@en
In vitro activity of gatifloxa ...... multidrug-resistant organisms.
@nl
prefLabel
In vitro activity of gatifloxa ...... multidrug-resistant organisms.
@en
In vitro activity of gatifloxa ...... multidrug-resistant organisms.
@nl
P2093
P356
P1476
In vitro activity of gatifloxa ...... multidrug-resistant organisms.
@en
P2093
Henry D Isenberg
Kenneth A France
Maria Agnes Dawis
Stephen G Jenkins
P304
P356
10.1093/JAC/DKG238
P407
P577
2003-04-14T00:00:00Z